MRNS - Marinus Pharmaceuticals Q4 2022 Earnings Preview
2023-03-06 17:35:39 ET
- Marinus Pharmaceuticals ( NASDAQ: MRNS ) is scheduled to announce Q4 earnings results on Tuesday, March 7th, after market close.
- The consensus EPS Estimate is -$0.75 (+2.6% Y/Y) and the consensus Revenue Estimate is $9.15M (+502.0% Y/Y).
- Over the last 1 year, MRNS has beaten EPS estimates 25% of the time and has beaten revenue estimates 50% of the time.
For further details see:
Marinus Pharmaceuticals Q4 2022 Earnings Preview